A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)
NCT07290062
·
clinicaltrials.gov ↗
PHASE1
Phase
RECRUITING
Status
23
Enrollment
INDUSTRY
Sponsor class
Conditions
Amyotrophic Lateral Sclerosis
Interventions
GENETIC:
INS1202
Sponsor
Insmed Gene Therapy LLC